Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro

Neoplasma

Volumn 51, Issue 6, 2004, Pages 460-464

  Bilir, A ^a   Guneri, A D ^a   Altinoz, M A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetaminophen; Breast cancer; DMSO; FM3A; Gemcitabine

Indexed keywords

ANTIOXIDANT; DIMETHYL SULFOXIDE; ENZYME INHIBITOR; FLAVOPIRIDOL; GEMCITABINE; GLYCOPROTEIN P; PARACETAMOL; RIBONUCLEOTIDE REDUCTASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL CYCLE S PHASE; COLONY FORMATION; DNA REPLICATION; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG EFFICACY; GROWTH INHIBITION; MEDIATOR RELEASE; NONHUMAN; SENSITIZATION;

EID: 11144234225     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BILIR A, ALTINOZ MA, ATTAR E, ERKAN M, AYDINER A. Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro. Neoplasma 2002; 49: 38-42.
2. BOULARES AH, GIARDINA C, INAN MS, KHAIRALLAH EA, COHEN SD. Acetaminophen inhibits NF-kappaB activation by interfering with the oxidant signal in murine Hepa 1-6 cells. Toxicol Sci 2000; 55: 370-375.
3. CHEN Y, SOKOLOSKIJ A, CHU E. Regulation of the expression of enzymes involved in the replication of DNA in chemically induced monocytic/macrophagic differentiation of HL-60 leukemia cells. Leuk Res 1998; 22: 697-703.
4. CHEN Y, SOKOLOSKI JA, CHU E, SARTORELLI AC. Regulation of the expression of enzymes involved in the replication of DNA in chemically-induced granulocytic differentiation of HL-60 leukemia cells. Leuk Res 1998; 22: 687-695.
5. CHEN S, ZHOU B, HE F, YEN Y. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA. Antisense Nucleic Acid Drug Dev 2000; 10: 111-116.
6. CORY JG. Ribonucleotide reductase as a chemotherapeutic target. Adv Enzyme Regul 1988; 27: 437-455.
7. CREASEY DC, WRIGHT JA. Involvement of ribonucleotide reductase in cellular differentiation. Biosci Rep 1984; 4: 299-309.
8. DICK JE, WRIGHT JA. Ribonucleotide reductase activity during the senescence of normal human diploid fibroblasts in culture. Mech Ageing Dev 1985; 32: 85-97.
9. DRASKOVIC-PAVLOVIC B, VAN DER LAAN LJ, PEJNOVIC N, DIJKSTRA CD, COLIC M. Differential effects of anti-rat CD11b monoclonal antibodies on granulocyte adhesiveness. Immunology 1999; 96: 83-89.
10. GIBSON JD, PUMFORD NR, SAMOKYSZYN VM, HINSON JA. Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chem Res Toxicol 1996; 9: 580-585.
11. HARNAGEA-THEOPHILUS E, GADD SL, KNIGHT-TRENT AH, DEGEORGE GL, MILLER MR. Acetaminophen induced proliferation of breast cancer cells involves estrogen receptors. Toxicol Appl Pharmacol 1999; 155: 273-279.
12. HARNAGEA-THEOPHILUS E, MILLER MR. Acetaminophen alters estrogenic responses in vitro: stimulation of DNA synthesis in estrogen-responsive human breast cancer cells. Toxicol Sci 1998; 46: 38-44.
13. HARNAGEA-THEOPHILUS E, MILLER MR, RAO N. Positional isomers of acetaminophen differentially induce proliferation of cultured breast cancer cells. Toxicol Lett 1991; 104: 11-18.
14. HONGSLO JK, BJORGE C, SCHWARZE PE et al. Paracetamol inhibits replicative DNA synthesis and induces sister chromatid exchange and chromosomal aberrations by inhibition of ribonucleotide reductase. Mutagenesis 1990; 5: 475-480.
15. HUANG P, CHUBB S, HERTEL LW, GRINDEY GB, PLUNKETT W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 1991; 51: 6110-6117.
16. JUNG CP, MOTWANI MV, SCHWARTZ GK. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit. Clin Cancer Res 2001; 7: 2527-2536.
17. KELLY KA, HILL MR, YOUKHANA K, WANKER F, GIMBLE JM. Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect Immun 1994; 62: 3122-3128.
18. MERRILL GF, GOLDBERG E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol 2001; 96: 423-430.
19. NOOTER K, STOTER G. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol Res Pract 1996; 192: 768-780.
20. QUELLET M, PERCIVAL MD. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 2001; 387: 273-280.
21. PANGANAMALA RV, SHARMA HM, HEIKKILA RE, GEER JC, CORNWELL DG. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins 1976; 11: 599-607.
22. RATNASINGHE D, DASCHNER PJ, ANVER MR, KASPRZAK BH, TAYLOR PR et al. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Res 2001; 21: 2141-2147.
23. SEIDMAN AD. The evolving role of gemcitabine in the management of breast cancer. Oncology 2001; 60: 189-198.
24. SHIMIZU S, SIMON RP, GRAHAM SH. Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats. Neurosci Lett 1997; 239: 125-127.
25. SOKOLOSKI JA, SARTORELLI AC, ROSEN CA, NARAYANAN R. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood 1993; 82: 625-632.
26. THATCHER NJ, EDWARDS RJ, LEMOINE NR, DOEHMER J, DAVIES DS. The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy. Cancer Gene Ther 2000; 7: 521-525.
27. WELDON CB, BUROW ME, ROLFE KW, CLAYTON JL, JAFFE BM, BECKMAN BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery 2001; 130: 143-150.
28. YIP-SCHNEIDER MT, SWEENEY CJ, JUNG SH, CROWELL PL, MARSHALL MS. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 2001; 298: 976-985.